Here are four things to know:
1. The study aims to assess the success of using Ceterix’s NovoStitch meniscal repair system or other suture-only techniques on horizontal meniscus tear repair and to assess improvements in knee pain and function after repair. The study targeted enrollment of 30 adults aged 60 or younger at 10 investigational sites in the U.S.
2. The NovoStitch meniscal repair system is designed to enable surgeons to place stitches arthroscopically in tight joint compartments and address complex knee, hip and shoulder injuries that have not been reparable in the past.
3. Meniscus surgeries are the most common arthroscopic surgery in the U.S., with roughly one million procedures performed annually.
4. Horizontal cleavage tears are often treated with partial removal of the meniscus despite meniscectomy’s limitations and long-term consequences, including a heightened risk of arthritis.
More articles on devices and implants:
OrthoXel’s Apex Tibial Nailing System receives approval to hit U.S. and European markets: 4 insights
Stryker, Smith & Nephew, Zimmer Biomet & more: 10 device company notes
College students enhance Encoris’ spine surgery training platform: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
